This brand name is authorized in Nigeria.
The drug HYPNOX contains one active pharmaceutical ingredient (API):
1
|
UNII
620X0222FQ - FLUNITRAZEPAM
|
|
Flunitrazepam is a member of the benzodiazepine group of drugs and is closely related to nitrazepam, flurazepam and clonazepam. It has marked sedative and hypnotic properties with a rapid onset of action and is used in severe cases of insomnia. |
|
This drug has been approved in Nigeria as follows:
| Identifier | Form | Presentation | Description | Approval |
|---|---|---|---|---|
| A11-0328 | Tablet | HYPNOX TABLETS TAB 1 mg 3x10 | 26 RNW-PP-309150 HYPNOX TABLETS FLUNITRAZEPAM 1MG FLUNITRAZEPAM 1MG A11-0328 Drugs Nigerian Products 3X10 POM 1 1/16/2023 FIDSON HEALTHCARE PLC, IKORODU ROAD, OBANIKORO LAGOS LAGOS 8023067964 nmakaokolo@yahoo.com Fidson Healthcare Plc., KM 38, Lagos- Abeokuta Expressway Sango-ota, Ogun State., Nigeria | 31/01/2024 |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| NG | Registered Drug Product Database | A11-0328 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.